Probiotic composition including lactic acid bacterial strains and use thereof

Disclosed herein is a probiotic composition that includes Lactobacillus salivarius subsp. salicinius AP-32, Lactobacillus johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9, which are deposited at the China Center for Type Culture Collection (CCTCC) respectively under accession numbers CCTCC M 2011127, CCTCC M 2011128, and CCTCC M 2014588. A number ratio of Lactobacillus salivarius subsp. salicinius AP-32, Lactobacillus johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 ranges from 1:0.1:0.1 to 1:1:8. Also disclosed herein is use of the probiotic composition for alleviating type 1 diabetes mellitus (T1DM)..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 27. Feb. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

HO HSIEH-HSUN [VerfasserIn]
LIN WEN-YANG [VerfasserIn]
KUO YI-WEI [VerfasserIn]
HUANG YEN-YU [VerfasserIn]
LIN JIA-HUNG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
C12R: Indexing scheme associated with subclasses c12c-c12 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-02-27, Last update posted on www.tib.eu: 2024-03-17, Last updated: 2024-03-22

Patentnummer:

US11911421

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000904244